NEWS RELEASE

Positive control for UUO kidney fibrosisNEW!!

2021.03.04

This ALK5 inhibitor has an inhibitory effect on the TGF-beta/ALK5 signaling pathway, which plays a central role in renal fibrosis.

READ MORE
NEWS RELEASE

Gannex Announces Positive Clinical Results in Overweight and Obese Subjects for Its THR-b Agonist ASC41

2021.02.22

Gannex (Shanghai, China) has announced positive clinical results in overweigth and obse subjects for its THR-b agonist ASC41.

READ MORE
NEWS RELEASE

TERNS announces FDA clearance of investigational new drug application for first-in-human phase 1 trial of TERN-501, its THR-beta agonist in development for the treatment of NASH

2021.02.15

TERNS Pharmaceuticals, Inc. (USA) has announced FDA clearance of investigational new drug aplication for first-in-human phase 1 trial of TERN-501, its THR-beta agonist in development for the treatment of NASH.

READ MORE

TOPICS

New Challenges, Explore New Ways!

Just an Action responsibly will lead us to the best way.
SMC is the Global Specialty CRO focuses on Non-clinical study.NEW!!

READ MORE
re-START! Next Step to Future

World together beyond COVID-19
SMC is responding to the coronavirus disease (COVID-19) outbreak. The information center provides news, guidance and resources as well as the information of related area.

READ MORE
Key Discoveries for new innovation

The Global CRO specialized in Non-clinical trial.
SMC provides the highest level of program management and clinical development services with the global value chain concept.

READ MORE

Our Original Patented "STAM™ mice" Technology

We contribute to society through state-of-the art non-clinical pharmacological research using our patented "STAM™ mice" technology
In order to develop new drugs, it is important to be able to accurately measure the effectiveness of drug candidates at a nonclinical trial stage.
Our "STAM™ mice" are disease model mice that more accurately reflect human pathology and therefore play a major role in pharmacology studies.

LEARN MORE

SMC Laboratories Service

SERVICE

CRO & CONSULTING INFO.

We support more than 600 pharmaceutical companies and bio-ventures in over 29 countries with our cutting-edge research and pharmacology studies.

LEARN MORE
SERVICE

THERAPEUTIC AREAS

Thanks to our extensive experience in various treatment fields, we are able to provide quick and decisive support for our client's pharmacological studies.

LEARN MORE
SERVICE

HISTOLOGY

Our expert pathologists support the construction of experimental analysis systems, data acquisition and explanation of results, and maximize the information from the histology samples of pharmacology studies conducted by clients.

LEARN MORE
TRIAL

TRIAL

Clients are able to perform preliminary research using both blood samples and various other biospecimens from the disease model mice that SMC offer.

LEARN MORE

* AND logical operation in case of multiple words.

Model cases

Services